Revolade tablets for Belfast's health trust come from Novartis
- Belfast Health and Social Care Trust
- Northern Ireland
- Direct award
- 7 July 2026 to 30 June 2028
Belfast Health and Social Care Trust is buying Revolade (eltrombopag) tablets from Novartis Pharmaceuticals UK. The contract covers the branded medicine in packs of 28 tablets, keeping a steady supply of the drug for the trust's patients.
The trust awarded the £1m contract directly to Novartis in June 2026, with no tender. It runs for two years, to June 2028.
Contract ends June 2028
- What
- Medicines supply
- Value
- £1m
- How it was bought
- Direct award
- Dates and next
- Jul 2026 to Jun 2028